“Health Canada is aware of reports of adverse events in
Europe following immunization with the AstraZeneca COVID-19 vaccine, and would
like to reassure Canadians that the benefits of the vaccine continue to
outweigh its risks,” the health department said in a statement.
“At this time, there is no indication that the vaccine
caused these events,” it said.
Canada received 500,000 AstraZeneca doses made at the Serum
Institute of India last week and expects to get 1.5 million more in by May.
“To date, no adverse events related to the AstraZeneca
COVID-19 vaccine… have been reported to Health Canada or the Public Health
Agency of Canada,” the statement said.
The federal government has ordered a total of 20 million
doses of the AstraZeneca vaccine and is due to receive 1.9 million through
COVAX – the international initiative set up to provide equitable access to
vaccines.
Although Canada has ordered more COVID-19 vaccine doses per
capita than any other country, its initial roll-out has been slow in part
because of temporary disruptions of deliveries from Pfizer Inc. and Moderna
Inc.
0 comments:
Post a Comment